Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 19950383)

1.

Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?

Bérard A.

Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):171-4. doi: 10.1002/bdra.20643. No abstract available.

PMID:
19950383
2.

Paroxetine exposure during pregnancy and cardiac malformations.

Scialli AR.

Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):175-7. doi: 10.1002/bdra.20655. No abstract available.

PMID:
20175190
3.

First trimester exposure to paroxetine and prevalence of cardiac defects: Meta-analysis of the literature: Unfortunately incomplete.

Einarson A, Koren G.

Birth Defects Res A Clin Mol Teratol. 2010 Jul;88(7):588; author reply 589. doi: 10.1002/bdra.20688. No abstract available.

PMID:
20602457
4.

First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.

Wurst KE, Poole C, Ephross SA, Olshan AF.

Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):159-70. doi: 10.1002/bdra.20627.

PMID:
19739149
5.

Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.

Einarson A.

Can Fam Physician. 2010 Aug;56(8):767-8. Erratum in: Can Fam Physician. 2010 Nov;56(11):1112.

6.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
7.

Does paroxetine cause cardiac malformations?

O'Brien L, Einarson TR, Sarkar M, Einarson A, Koren G.

J Obstet Gynaecol Can. 2008 Aug;30(8):696-701.

PMID:
18786292
8.

Paroxetine may increase risk for congenital malformations.

Cuzzell JZ.

Dermatol Nurs. 2006 Feb;18(1):68. No abstract available.

PMID:
16617525
9.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.

Gentile S, Bellantuono C.

J Clin Psychiatry. 2009 Mar;70(3):414-22. Epub 2009 Feb 24. Review.

PMID:
19254517
10.

SSRI antidepressants and birth defects.

[No authors listed]

Prescrire Int. 2006 Dec;15(86):222-3.

PMID:
17167929
11.

Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy.

Einarson A.

J Clin Psychiatry. 2012 Nov;73(11):1443-6. doi: 10.4088/JCP.12com08192. No abstract available.

PMID:
23218161
12.

Paroxetine in the first trimester and the prevalence of congenital malformations.

Cole JA, Ephross SA, Cosmatos IS, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1075-85.

PMID:
17729379
13.

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.

Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A.

Br J Clin Pharmacol. 2008 Nov;66(5):695-705. doi: 10.1111/j.1365-2125.2008.03261.x. Epub 2008 Jul 11.

14.

An imperfect literature and evidence-based medicine.

Freeman MP.

J Clin Psychiatry. 2009 Mar;70(3):412-3. doi: 10.4088/JCP.09f05050. No abstract available.

PMID:
19317958
15.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
16.

Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

Malm H, Artama M, Gissler M, Ritvanen A.

Obstet Gynecol. 2011 Jul;118(1):111-20. doi: 10.1097/AOG.0b013e318220edcc.

PMID:
21646927
17.

Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.

Hallberg P, Odlind V, Sjöblom V.

N Engl J Med. 2006 May 18;354(20):2188-90; author reply 2188-90. No abstract available.

PMID:
16710910
18.

First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

Bakker MK, Kerstjens-Frederikse WS, Buys CH, de Walle HE, de Jong-van den Berg LT.

Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):94-100. doi: 10.1002/bdra.20641.

PMID:
19937603
19.

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.

Källén BA, Otterblad Olausson P.

Birth Defects Res A Clin Mol Teratol. 2007 Apr;79(4):301-8.

PMID:
17216624
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk